SuperworthDecoy Therapeutics market cap DCOY
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $635.5K
- Highest close in our data
- $404.6M
- Apr 2015
Decoy Therapeutics is worth $635.5K at the close on Oct 23, 2026, at $0.97 a share.
That is down 68% over the last year and down 98% over five years.
Its highest close in our data was $404.6M in Apr 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $635.5K | $635.5K | $5.3M | −84% |
| 2025 | $3.9M | $611.6K | $5.5M | +60% |
| 2024 | $2.4M | $1.1M | $2.9M | −6% |
| 2023 | $2.6M | $2.1M | $6.8M | −27% |
| 2022 | $3.5M | $2.7M | $22M | −84% |
| 2021 | $22.4M | $22M | $69.8M | +24% |
| 2020 | $18.1M | $2.7M | $23.2M | +13% |
| 2019 | $16M | $3.2M | $16.6M | +192% |
| 2018 | $5.5M | $5.5M | $136.6M | −91% |
| 2017 | $62.7M | $50.3M | $98.8M | −34% |
| 2016 | $94.9M | $84.1M | $227.5M | −58% |
| 2015 | $223.4M | $188.9M | $404.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Decoy Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DCOYDecoy Therapeutics | $635.5K |
| SBFMSunshine Biopharma | $581.6K |
| JAGXJaguar Health | $702.9K |
| LABTLakewood-Amedex Biotherapeutics | $734.6K |
| NXTSNexentis Technologies | $761.8K |
| VBIOValion Bio | $834.3K |
| ARTLArtelo Biosciences | $1.3M |
| LNAILunai Bioworks | $1.5M |
| GNPXGenprex | $1.5M |
| GOVXGeoVax Labs | $1.5M |
| ONCOOnconetix | $1.7M |
| Peer median | $1.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Decoy Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.